These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 29493875)
1. Efficiency of physiotherapy with Caycedian Sophrology on children with asthma: A randomized controlled trial. Romieu H; Charbonnier F; Janka D; Douillard A; Macioce V; Lavastre K; Abassi H; Renoux MC; Mura T; Amedro P Pediatr Pulmonol; 2018 May; 53(5):559-566. PubMed ID: 29493875 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study. Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of formoterol Turbuhaler when added to inhaled corticosteroid treatment in children with asthma. Zimmerman B; D'Urzo A; Bérubé D Pediatr Pulmonol; 2004 Feb; 37(2):122-7. PubMed ID: 14730657 [TBL] [Abstract][Full Text] [Related]
4. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma. Tal A; Simon G; Vermeulen JH; Petru V; Cobos N; Everard ML; de Boeck K Pediatr Pulmonol; 2002 Nov; 34(5):342-50. PubMed ID: 12357478 [TBL] [Abstract][Full Text] [Related]
5. Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long-term treatment with inhaled corticosteroids. Dutch CNSLD Study Group. Brand PL; Duiverman EJ; Waalkens HJ; van Essen-Zandvliet EE; Kerrebijn KF Thorax; 1999 Feb; 54(2):103-7. PubMed ID: 10325912 [TBL] [Abstract][Full Text] [Related]
6. Using quality-control analysis of peak expiratory flow recordings to guide therapy for asthma. Gibson PG; Wlodarczyk J; Hensley MJ; Murree-Allen K; Olson LG; Saltos N Ann Intern Med; 1995 Oct; 123(7):488-92. PubMed ID: 7661491 [TBL] [Abstract][Full Text] [Related]
7. Addition of formoterol or montelukast to low-dose budesonide: an efficacy comparison in short- and long-term asthma control. Ceylan E; Gencer M; Aksoy S Respiration; 2004; 71(6):594-601. PubMed ID: 15627870 [TBL] [Abstract][Full Text] [Related]
8. The Effect of Salt Space on Clinical Findings and Peak Expiratory Flow in Children with Mild to Moderate Asthma: A Randomized Crossover Trial. Mazloomzadeh S; Bakhshi N; Ahmadiafshar A; Gholami M Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):198-204. PubMed ID: 28732433 [TBL] [Abstract][Full Text] [Related]
9. A randomized clinical trial of magnesium sulphate as a vehicle for nebulized salbutamol in the treatment of moderate to severe asthma attacks. Kokturk N; Turktas H; Kara P; Mullaoglu S; Yilmaz F; Karamercan A Pulm Pharmacol Ther; 2005; 18(6):416-21. PubMed ID: 15953743 [TBL] [Abstract][Full Text] [Related]
10. [Round Table: Severe asthma in pediatrics: treatment of acute crises]. García Martínez JM Allergol Immunopathol (Madr); 1999; 27(2):53-62. PubMed ID: 10354007 [TBL] [Abstract][Full Text] [Related]
11. Salmeterol xinafoate in children on high dose inhaled steroids. Russell G; Williams DA; Weller P; Price JF Ann Allergy Asthma Immunol; 1995 Nov; 75(5):423-8. PubMed ID: 7583864 [TBL] [Abstract][Full Text] [Related]
12. Time course of change in oxygen saturation and peak expiratory flow in children admitted to hospital with acute asthma. Mihatsch W; Geelhoed GC; Landau LI; LeSouëf PN Thorax; 1990 Jun; 45(6):438-41. PubMed ID: 2392787 [TBL] [Abstract][Full Text] [Related]
13. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler. Murphy K; Noonan M; Silkoff PE; Uryniak T Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study. Lee YS; Lin HC; Huang CD; Lee KY; Liu CY; Yu CT; Wang CH; Kuo HP Chang Gung Med J; 2011; 34(4):382-94. PubMed ID: 21880193 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study. Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma. Medley H; Orozco S; Allen A Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247 [TBL] [Abstract][Full Text] [Related]
17. [Round Table: Severe asthma in pediatrics: diagnosis and prognosis]. Garde Garde JM; Medina Pomares J Allergol Immunopathol (Madr); 1999; 27(2):46-53. PubMed ID: 10354006 [TBL] [Abstract][Full Text] [Related]
18. Reversal of bronchial obstruction with bi-level positive airway pressure and nebulization in patients with acute asthma. Brandao DC; Lima VM; Filho VG; Silva TS; Campos TF; Dean E; de Andrade AD J Asthma; 2009 May; 46(4):356-61. PubMed ID: 19484669 [TBL] [Abstract][Full Text] [Related]
19. Proventil HFA and ventolin have similar safety profiles during regular use. Tinkelman DG; Bleecker ER; Ramsdell J; Ekholm BP; Klinger NM; Colice GL; Slade HB Chest; 1998 Feb; 113(2):290-6. PubMed ID: 9498941 [TBL] [Abstract][Full Text] [Related]
20. Budesonide/formoterol improves lung function compared with budesonide alone in children with asthma. Pohunek P; Kuna P; Jorup C; De Boeck K Pediatr Allergy Immunol; 2006 Sep; 17(6):458-65. PubMed ID: 16925692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]